Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Oct;31(10):1997-2002.
doi: 10.1007/s00192-020-04407-0. Epub 2020 Jul 21.

The international discussion and the new regulations concerning transvaginal mesh implants in pelvic organ prolapse surgery

Nathalie Ng-Stollmann  1 , Christian Fünfgeld  2 , Boris Gabriel  3   4 , Achim Niesel  5
Affiliations
Review

The international discussion and the new regulations concerning transvaginal mesh implants in pelvic organ prolapse surgery

Nathalie Ng-Stollmann et al. Int Urogynecol J. 2020 Oct.

Abstract

The use of transvaginal mesh implants for POP and urinary incontinence is currently being extensively debated among experts as well as the general public. Regulations surrounding the use of these implants differ depending on the country. Although in the USA, the UK, in Canada, Australia, New Zealand, and France, transvaginal mesh implants have been removed from the market, in most mainland European countries, Asia, and South America, they are still available as a surgical option for POP correction. The aim of this review is to provide an overview of the historical timeline and the current situation worldwide, as well as to critically discuss the implications of the latest developments in urogynecological patient care and the training of doctors.

Keywords: Alloplastic meshes; Pelvic organ prolapse; Regulations; Transvaginal mesh implants; Urinary incontinence.

PubMed Disclaimer

Conflict of interest statement

Nathalie Ng-Stollmann: none; Christian Fünfgeld: consultant for Serag-Wiessner, A.M.I, PFM (acceptance of paid travel expenses and honoraria); Boris Gabriel: Serag-Wiessner (acceptance of paid travel expenses and honoraria); Achim Niesel: consultant for Serag-Wiessner, A.M.I (acceptance of paid travel expenses and honoraria).

References

    1. Wu JM, Hundley AF, Fulton RG, Myers ER. Forecasting the prevalence of pelvic floor disorders in U.S. women: 2010 to 2050. Obstet Gynecol. 2009;114:1278. doi: 10.1097/AOG.0b013e3181c2ce96. - DOI - PubMed
    1. Downing KT (2012) Uterine prolapse: from antiquity to today. 2012;2012:649459. - PMC - PubMed
    1. Ugianskiene A, Davila GW, Su T-H. FIGO review of statements on use of synthetic mesh for pelvic organ prolapse and stress urinary incontinence. Int J Gynecol Obstet. 2019;147:147–155. doi: 10.1002/ijgo.12932. - DOI - PubMed
    1. Heneghan CJ, Goldacre B, Onakpoya I, et al. Trials of transvaginal mesh devices for pelvic organ prolapse: a systematic database review of the US FDA approval process. BMJ Open. 2017;7:e017125. doi: 10.1136/bmjopen-2017-017125. - DOI - PMC - PubMed
    1. Maher C, Baessler K, Glazener CMA, et al. Surgical management of pelvic organ prolapse in women: a short version Cochrane review. Neurourol Urodyn. 2008;27:3–12. doi: 10.1002/nau.20542. - DOI - PubMed